Parker Institute for Cancer Immunotherapy-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2020

  1. Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

    Cancer Cell, Vol. 38, Núm. 4, pp. 500-515.e3